New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma - Wikidata - wikimedia - TriplyDB

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

http://www.wikidata.org/entity/Q36144084

about

Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.Emerging therapies for adult soft tissue sarcoma.Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells.Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review Inflammatory stress and sarcomagenesis: a vicious interplay.Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.The molecular biology of soft-tissue sarcomas and current trends in therapy.Safety and accuracy of core biopsy in retroperitoneal sarcomas.

P2860

Q34005286-FDE182F7-0932-4D08-A934-7AD0B8C133D6 Q34659806-13C3749E-E003-4214-976C-D48C8A6E3400 Q35647795-FFA73677-04E1-4909-8781-4FBF45BBA768 Q37153843-770728B4-31CD-4A4A-9AC2-7DDB3982B28A Q37378867-BFB8763E-6368-4757-95E7-3A83C962C597 Q38131047-16F643BC-E723-47A0-A0D6-24D1BD0FB8AD Q40804607-E84F72FC-77DB-416D-97D0-8C5252D1F4CB Q42177224-B192FBF3-D424-4CA3-B56B-F753C5746E8C Q43543250-AD2AB1DC-240B-4844-A578-9C854D94A3D0

P2860

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

http://www.wikidata.org/entity/Q36144084

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

@ast

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

@en

type

label

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

@ast

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

@en

prefLabel

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

@ast

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

@en

P1433

Q36144084-77BD0CB2-B138-4AD7-86F9-A271D63E66A6

P1476

Q36144084-5C6DF282-2086-4C79-AD91-0685F1AFC137

P2093

Q36144084-4094295D-72DE-4B31-B654-029E6BFC0C30

P275

Q36144084-E9FE97F6-E7DB-48E8-A150-BAF6AAEFE2AF

P2860

Q36144084-08CF2A49-4AB1-4EE2-B31B-2F3D6B5AED0C

Q36144084-0C0D7C54-4A12-4039-B16F-3AC5D1F1B029

Q36144084-0CCDC3BD-9EE6-4C3A-9C23-02B186C418B8

Q36144084-0F1472BD-59BD-424A-83C6-C3FD23785C1F

Q36144084-130F73B2-665A-45F0-89BB-6558FA4EB97E

Q36144084-154502B3-56D8-4B6B-99F4-ACC4E73D4802

Q36144084-16AC144B-5B86-4A50-AB02-734593E05CAA

Q36144084-174B52EC-9EFA-4E76-948D-7593FD04BF31

Q36144084-19CD5D1E-87F5-4268-9E89-510C251B606F

Q36144084-1C7FA750-D885-46B5-8A30-186E29E9E202

P304

Q36144084-80C09CDC-9EA0-4938-9938-3BF227B132E2

P31

Q36144084-2FCCF4DE-8E61-40D6-9DD7-E7D95F38CDAF

Q36144084-BBF9DCC7-C4E0-47E4-803D-D51810FF2AA1

P356

Q36144084-014C8999-07B8-43A6-8AB5-97E6FC2DD341

P407

Q36144084-006F85A9-CE04-4D2E-A958-BA1668CFF3C8

P433

Q36144084-FFC0B137-06DA-4C3A-BA5A-9C765DAF7637

P478

Q36144084-0509AF34-98B6-43C7-A587-EA18F6736D8C

P5008

Q36144084-2F4B86BF-3050-4FB7-822F-2AEB4D34097F

P577

Q36144084-136A17DB-8C21-4A57-91AC-5AF3463A8187

Q36144084-6A0525D6-C172-4282-AE77-B01A5DEB57F5

P5875

Q36144084-C2E1DDFD-37C0-4663-A399-080DF60101C1

P698

Q36144084-63885683-DE50-437E-A33D-AF9A97838C11

P921

Q36144084-17494ECF-B788-4888-BC69-55D51925EC52

Q36144084-20C7386E-271D-45C2-9C38-DDB30E852ED6

Q36144084-49DB3FE5-A2FF-4C68-8C6F-D608AEFF409B

Q36144084-D1F1D644-65A4-4970-9F04-949A6E1049F0

P932

Q36144084-18E09ED6-9724-44B1-BE11-19C5AE455A4E

P356

P1433

P1476

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

@en

P2093

Mark Agulnik

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

Production of novel rapamycin analogs by precursor-directed biosynthesis.

CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling

Targeting HIF-1 for cancer therapy

Current development of mTOR inhibitors as anticancer agents

Upstream and downstream of mTOR

The TOR pathway: a target for cancer therapy

Molecular mechanisms of mTOR-mediated translational control

Clinical pharmacokinetics of everolimus.

Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer.

P304

1486-1497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.26361

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2012-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51567640

http://www.w3.org/2001/XMLSchema#string

P698

21837674

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

epithelioid sarcoma

P932

3412949

http://www.w3.org/2001/XMLSchema#string